Steini, in this case the $300m buyout was of a somewhat disadvantaged
company whose main researchers were probably happy to go along
for the ride....In short, they were happy to be taken over...
I'm not sure Imugen research scientists would be happy to be usurped
into a conglomerate and basically just be numbers.....
Axel and Leslie would be prime requirements for any takeover to
be agreed to, not sure how they would react....
Merck, for example, explaining their recent M&A record of doing little
put some of the blame on desired targets not being will to sell....
Steini, in this case the $300m buyout was of a somewhat...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
